Altogether, based on our bioinformatics analysis and functional validation experiments these results established a link between PRL/PRLR and Hippo pathway and as an important negative regulator of YAP-CCN2 pathway in breast cancer. This evidence concerns the gene PRLR and breast carcinoma.